TL;DR: Tesla Japan essentially out of inventory. Q3 delivery to start in late Aug.
S/X/3 summry.
No new inventory listed, just a few CPOs.
Glovis Splender will arrive in ~1wk & prep for delivery is in full swing. Even those who ordered in June/July are getting paperwork, so they seem to be intent on clearing the entire backlog in one shipment. Note that no Model 3 shipment since last yr, most likely since Nov.
My estimate for this yr was 300/Q for 1H, 200/Q for 2H. They delivered some in Q1 (100~150) from inventory, so this will be 2.5Q worth of deliveries in one Q.
My estimate (& rumor on the forum) is ~300 backlog & ~200 from Q3. If they're intent on delivering all, that's ~500.
I thought they'd do ~400/300 in Q3/Q4, but they seem to be pushing for ~500/200.
What's nice this Q is that shipment is early enough that we'll know how many was on that ship before Q3 ends. My guess ATM is 700~800, w/ 200 or so of them S/X.
Q3 orders are similar to Q1 (Q2 was low, obviously). But backfilling has been quite high for several wks, because many are entering data as they get the paperwork. i.e. when they report orders, rather than when they order, has been a better proxy for deliveries.
Here's the monthly orders reported. Early on, sampling rate was ~20%.
102 orders reported since NOV, so ~500 at 20% rate. The deliveries out of inventory in Q1 & cancellation (reportedly high) prob. cancel out a drop in sampling rate.
The only Q wrt Q3 delivery is if they can do 500 in a bit over a month. The most they've done is ~290 in Sept. '19, the first month of Model 3 delivery. They may not have the infrastructure to do 500 in Q3.
At the end of July, Tesla has 0.012% JPN market share for 2020, ~4.2% of BEV share (Leaf has >90% share). Model 3 hasn't made the quarterly top 20 import list.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
If anything S.Korea had more cases than usual, but fewer hospitalization. That makes sense, given that RSV is worse in <1. Delayed infection is a good thing.
What's ironic is that, if you follow the logic of "immunity debt" enthusiasts (charitably, tbf), you end up concluding that "freedom day" was even dumber than we already thought.
1/
For one, we know infection-induced immunity to many of these pathogens is fairly shot-lived. i.e. what happened yrs ago doesn't really matter.
2/
For another, not all pathogens are created equal. Some are more infectious/harder to control.
3/
Variant-specific PCR says suspected BA.5 was ~3/4 during 7/5~7/11. Almost all suspected BA.5 for the latest wk (7/12~7/18).
2/
Similar story for Kobe. L452R+ > 80% for 7/11~7/17 (1st table). Majority of sequences (2nd table) from 7/4~7/10 were BA.5. They show BA.2.12.1 under BA.2 in ( ), BA.2.75 in [ ].
Mini-thread on JPN Covid mortality data wrt "from" vs. "with".
(Meaning to do this since MHLW advisory board posted some useful data a month ago, so here it is.)
tl;dr: Covid is still the primary cause in majority of reported deaths & Omicron is bad.
1/
MHLW guideline essentially requires all deaths by Covid patients be reported, so the reported #s include some incidental cases. So what % is incidental?
2/
First, data from Kanagawa pref. (pop. 9.2m, 2nd largest) on the "primary" causes of death in Jan/Feb '22 (almost all Omicron).
Primary cause: 53.2%
Not primary cause: 32.1%
Undetermined: 14.7%
Note that "not primary cause" doesn't mean it wasn't a contributing factor.
2 lines overlapping for Alpha = ~2% CFR
Same for Delta & Omicron = ~0.3% CFR
Note the differences in Y-axes.
Most seniors got vaccinated after the peak of Alpha wave. Others during the Delta wave.
1/
Omicron wave is likely to peak next wk (likely already did in southern/western 1/3 of the country), so deaths likely to peak in late Feb. Looking like it'll be the deadliest wave so far.
2/
Roughly,
Spring '20: 1k
Summer/Autumn '20: 1k
Winter '20-'21: 7.5k
Spring '21 (Alpha): 7.5k
Summer '21 (Delta): 3k
Winter '22 (Omicron): ~800 so far.
Per case severity is clearly lower relative to pre-vaxx peaks, but high transmissibility makes that less relevant.
3/